Objectives: To evaluate the quality of life (QoL) of the patients after extracorporeal shockwave lithotripsy (ESWL) on a treated stone size related basis. Methods: 90 patients undergoing ESWL for kidney stones were divided into three groups; Group 1 (n: 30, ≤ 10 mm), Group 2 (n: 28, 11 mm-≤ 20 mm) and Group 3 (n: 32, 20-25 mm). During 3-months follow-up, outcome of the procedure, number of cases with emergency department visits, analgesic required, re-tretatment rates, additional procedures and the changes in the QoL were evaluated. Results: the number of emergency department visits and mean analgesic need; re-treatment rates and additional procedures were significantly higher in Group 3. Evaluation of the QoL scores in three groups showed that cases with larger stone still had lower scores during 3-month evaluation. Conclusions: Stone size could help us to predict the possible impact of ESWL on the QoL and depending on the size of the stone treated, a well planned indication and effective management possibly by an experienced urologist could limit the changes in the QoL of the patients.
expected (33-65%) (10) . In their original study, Abe et al. reported that of the 267 patients undergoing ESWL for stones sizing between 20 and 30 mm.,46% were SF, while residual fragment were present in 54% (11) . Thus, despite a safe and successful disintegration, depending on the stone size, SFR could vary in a considerable percent of the cases (6, 12) . The associated symptoms and morbidity during the passage of disintegrated fragments might have significant effects on these patients' QoL (4, 13, 14) . Thus, it becomes more important that endourologists should not solely focus on the SF obtained but also on the changes in psychological, functional, social and economic life of the patients after ESWL which may possibly change well during the clinical course and the repeated sessions and/or additional procedures after ESWL (4, 5, 15) . QoL is an estimate of freedom from impairement, disability or handicap (16) . The quantification of QoL has been extensively reported in patients with a wide variety of diseases and well assessed in many health problems as well as after certain medications and/or procedures (17) . However, to our knowledge highly limited data regarding the QoL of the stone formers after certain endourological procedures could be derived from the literature (13, 14, 18) and our current study is the first study focusing solely on the QoL changes in cases undergoing ESWL in a standardized and detailed manner. In this prospective study we aimed to evaluate the changes in the QoL of the patients after ESWL on a treated stone size based manner.
MATERIALS AND METHODS
Between May 2012 and December 2012, a total of 90 patients (53 men, 37 women; M/F: 1.4) undergoing ESWL for solitary radioopaque renal pelvis stones were included into this prospective study program. Patients with established contraindications for ESWL were excluded. A detailed information about the procedure were given to all cases with an informed consent prior to ESWL. Patients were divided into three subgroups with respect to the treated stone size. Group 1 (n:30) Patients with stones sizing ≤ 10 mm, Group 2 (n: 28) 11 mm-≤ 20 mm, and Group 3 (n:32) 21-25 mm. Following routine biochemical tests; plain KUB, sonography and noncontrast computed tomography (NCCT) were per-
INTRODUCTION
Urolithiasis is a worldwide health problem (1, 2) which typically affects the social life of the patients during their most active and productive age between 20 and 50 years (3, 4) . In addition to the distressing pain, obstruction and recurrent infections, decreased productivity, loss of work time are the adverse outcomes of stone disease (5, 6) . Regarding the treatment, although ESWL has revolutionized the management of urinary calculi with its highly effective results (2), a considerable percentage of the patients may require additional procedures (7, 8) . Success as well as re-treatment rates after ESWL are related to some certain patient and stone related factors among which the stone sizeis the most crucial one (8, 9) . As the stone burden increases (> 20 mm), the SF-rate (SFR) decreases in a considerable extent with high reretreatment rates (6) . SFR after ESWL monotherapy in patients with larger stones (20-30 mm) are lower than formed. Stone size has been assessed by NCCT in all cases. ESWL was performed by an electromagnetic (Dornier Compact Sigma, Dornier MedTech Germany) lithotriptor with a maximum shockwave number of 3000 in a session at 120 kV values. Outcome of ESWL was assessed after 1-week and depending on the size of fragments further sessions have been performed with a 1-week interval between each ESWL session. The overall outcome of ESWL was evaluated 3 months after the last session and while the cases with no fragment(s) were accepted as SF, cases with fragments as well as with no documented disintegration after 3 successful sessions were accepted as not SF.To evaluate the cases first plain KUB and sonography were performed in all cases and NCCT was performed in a case dependant manner when needed to assess the presence and size of fragments. Spontaneous passage rates, cases referring to ED visits, analgesic required (Diclofenac sodium 75 mg IM at each referral); additional procedures and also the changes in the QoL were assessed during 1 and 3 months after ESWL. Changes in QoL were evaluated by giving SF-36® questionnaire filled at hospital conditions. First the overall baseline QoL scores before the procedure were evaluated and noted then the QoL scores after SWL were obtained and compared with the baseline scores before making an inter sub-group comparison. The Medical Outcome Study SF-36 Turkish version 1.0 was used to assess QoL (19) . This questionnaire consists of 36 self-administered questions that quantify QoL using eight multi-item scales: General health (GH), Physical functioning (PF), Role physical (RP), Bodily pain (BP), Vitality (VT), Social functioning (SF), Mental health (MH) and Role emotional (RE) (20) . The eight scales were scored separately from 0 to 100, with a higher score being indicative of a better result, and these scores were used for analyses of the comparisons among the groups. Stone size and quality of life: A critical evaluation after extracorporeal shock wave lithotripsy Table 2 . Evaluation of the mean analgesic requirement and emergency department visit in all sub-groups. to all 8 subdomains were present in all of them during 1-month follow-up (Figure 1 a) . However, at 3-month follow-up this evaluation showed an evident improvement in the mean QoL scores of the first group (≤ 10 mm) where the values found to be similar to baseline (before ESWL) data. In the second group again (11 mm-≤ 20 mm) these scores improved in a considerable extent where there was a significant difference with respect to only one subdomain (GH, p = 0.018). 
Statistical Analysis

DISCUSSION
Urolithiasis is a major problem particularly in endemic countries (1, 2) . In addition to the disease related bothersome symptoms; fragments forming after certain stone removal procedure(s) and related interventions can also be associated with a variety of distressing symptoms which may worsen over time (15) . Among these symptoms colic pain, obstruction and recurrent infections resulting in decreased productivity, loss of work time or employment are the most prominent ones (5, 6). Currently ESWL, URS and PNL are well-established procedures for stone removal.
Regarding the procedure related advantages and disadvantages; selection should be based on certain stone and patient related factors (2) . Although ESWL is the management of choice for most stones with its efficient and safe natüre (2); studies demonstrated that despite an effective disintegration, sponta neous passage and in some cases removal of the fragments may be needed for a completely SF status. Long-term follow-up data in large number of patients has clearly shown that 23% to 54% of the cases undergoing ESWL may have residing fragments after this procedure (11, 12) . Regarding the clinical course after ESWL although majority of disintegrated stone particles may pass spontaneously or stay in situ asymptomatic; they may be symptomatic and/or obstructive in a certain percent of the cases. Obstruction induced symptoms and morbidity casued by these fragments could cause significant changes in patients' QoL (4, 13, 14) . Furthermore, they may necessitate pain management, ED visits, hospitalization, or even additional procedures that may further worsen the long-term QoL. Regarding the success rates, data in the literature show that while the SFafter ESWL monotherapy are meaningfully higher in stones sizing < 20 mm (80-85%) (2, 6) Figure 1a . Evaluation of QoL scores during 1-month evaluation in all sub-groups.
Figure 1b.
Evaluation of the QoL scores during 3-month evaluation in all sub-groups these rates are reasonably lower (33-65%) in larger stones (20- (20-30 mm) , while 46% of the cases became SF, 54% did still have RF during follow-up (11) . Lastly "The American Urological Association Nephrolithiasis Clinical Guidelines Panel" data emphasized that the re-retreatment rates increases from 12% for stones < 10 mm up to 46% for stones > 30 mm (24) . Finally, recommendation made by NIH Consensus Conference indicated that patients with stones > 20 mm were offered PNL initially due to the higher re-treatment rates and the need for auxiliary procedures (10) . Thus, the stone size is an important parameter to predict the re-treatment rates and auxiliary procedures after ESWL. However endourologists so far, followed the patients solely with respect to the success rates without giving any attention for the changes in patient' s QoL. Procedure itself, stone fragments resided as well as the additional procedures required could affect the QoL and the endourologists should not solely focus on the final outcome but also on these important changes (4, 5, 15) . Such a perspective is particularly true in socially active aged cases undergoing ESWL (13, 14) . To our knowledge detailed data focusing on the QoL changes after ESWL therapy particularly on a treated stone size based manner is reasonably lacking. In the limited number of studies published so far the authors either evaluated QoL changes after different procedures in a comparative manner or focused on the patient preferences in the treatment of urinary stones (14, 15, 26) . In this present study, apart from the evaluation of the efficacy of ESWL, we aimed to evaluate the changes in the QoL of the patients with an emphasis on the treated stone size during 1 and 3-month follow-up period. Patients with larger stones (> 20 mm) tended to have an impaired QoL as a result of the higher re-treatment rates as well as colic pain requiring ED visits forrelatively larger fragments. Again, mean QoL scores in such patients were compared with baseline (before ESWL) scores during both 1 and 3 month follow-up and while significantly lower scores for all 8 subdomains were noted in all sub groups during 1-month period; during 3-months however values in the first group were similar to baseline (before ESWL) data. Again QoL scores improved in the second group with lower values only for one subdomain (GH). However the improvement of QoL scores in cases with larger stones (> 20 mm) was highly limited with statistically significant lower mean scores in 6 subdomains. To support these findings further, mean analgesic use and the ED visits were significantly higher in patients with such stones. Thu, although ESWL is considered as the least invasive alternative for the majority of the stones, in the light of our data evaluation of the QoL of in these cases gains a meaningful importance by bringing the question in front of the endorologists as "obtaining a completely SF status after ESWL -at the expense of what?" Clinical studies published so far focused mainly on success rates in terms of SF status; possible changes in the QoL of these cases have not been subjected to any of these studies in an attempt to outline the certain factors affecting such changes. These possible changes should be kept in mind and monitored with as much attention as given for the evaluation of the final outcome of the procedure. Again, the evident QoL changes in patients with larger stones (> 20 mm) may let the endourologists to consider a proper tretament plan in favour of other minimal invasive procedures in these cases. Concerning the limitations, limited the number of cases could be the only certain drawback of our study. However, as this one is the first in the literature evaluating the QoL after ESWL in a stone size based manner; we believe that our study will certainly give an idea in defining the importance of changes in QoL a topic which was not evaluated in detail so far.
CONCLUSIONS
Although ESWL is a safe and effective procedure; despite a successful stone disintegration, higher re-treatment rates, residing fragments and additional procedures particularly in cases with relatively larger stones (> 20 mm) could significantly affect the QoL of these cases. Depending on the stone size, a proper indication and effective management possibly by an experienced urologist could limit the possibility of factors responsible for the changes in the QoL.
